PróGenéricos
Membership Organizations · Brazil · 11-50 Employees
View Company Info for Free
Overview
Headquarters
BrazilWebsite
www.progenericos.org.brRevenue
$8.2 MillionIndustry
About PróGenéricos
PróGenéricos Org Chart
Is PróGenéricos your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at PróGenéricos
Funding: Get notified immidiatlly once PróGenéricos has new funding data
PróGenéricos, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on PróGenéricos recently announced quarterly report
Click to see if PróGenéricos had a recent Job posting/layoffs
Check out if PróGenéricos is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when PróGenéricos launches new products
Check if PróGenéricos has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined PróGenéricos as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
PróGenéricos is experiencing very low activity levels compared to other companies in the Organizations sector.
What does this means?
PróGenéricos is drawing exceptional interest within the Organizations industry, suggesting notable developments or strong market momentum, learn more about PróGenéricos.
PróGenéricos Tech Stack
A closer look at the technologies used by PróGenéricos
Top Membership Organizations Companies
Frequently Asked Questions Regarding PróGenéricos
PróGenéricos is an association representing industries dedicated to the research, production, and commercialization of generic and biosimilar medications in Brazil. With over two decades of experience, the organization actively participates in regulatory discussions and advocates for policies that enhance healthcare access and innovation. It serves... Read More